Safety and Efficacy of Azacitidine, and Thalidomide in Higher Risk MDS (Myelodysplastic Syndrome)
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndrome
Related studies linked through entity extraction aliases.
A Dose Range Finding Study of Lenalidomide in Non-5q Chromosome Deletion in Low and Intermediate Risk Myelodysplastic Syndrome (MDS) Patients
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Reduced Intensity Conditioning With Clofarabine, Antithymocyte Globulin (ATG), Total Lymphoid Irradiation (TLI) Followed by Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Pilot Study of Haploidentical Natural Killer Cell Infusions for Poor Prognosis Non-AML Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Anti-Disease Activity of CHR-2797 (Tosedostat) in Elderly and/or Treatment Refractory Patients With Acute Myeloid Leukemia (AML) and Multiple Myeloma (MM)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Temozolomide in Previously Untreated Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Participants With Low O6-Methylguanine Methyltransferase (MGMT) Expression (P05052)
- Status
- COMPLETED
- Phase
- PHASE2
Total Marrow Irradiation for Refractory Acute Leukemia
- Status
- COMPLETED
- Phase
- PHASE1
INCB018424 in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Donor Lymphocyte Infusion (DLI) and Activated DLI Following Relapse After Allogeneic Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE1
Targeted Atomic Nano-Generators (Actinium-225-Labeled Humanized Anti-CD33 Monoclonal Antibody HuM195) in Patients With Advanced Myeloid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML
- Status
- TERMINATED
- Phase
- PHASE1
Deferoxamine for Iron Overload Before Allogeneic Stem Cell Transplantation
- Status
- TERMINATED
- Phase
- NA
A Randomized Trial of Procrit vs. No Procrit in AML and High Risk MDS
- Status
- COMPLETED
- Phase
- PHASE3
Rituximab (Rituxan) for the Prevention of EBV-LPD Epstein Barr Virus (EBV) Lymphoproliferative Disorder Post T Cell Depleted Unrelated and HLA Mis-matched Related HSCT
- Status
- COMPLETED
- Phase
- NA
Pilot Study of Expanded, Donor Natural Killer Cell Infusions for Refractory Non-B Lineage Hematologic Malignancies and Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clofarabine and Non-Myeloablative Allogeneic Hematopoietic Transplantation
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Cephalon Decitabine, Arsenic Trioxide and Ascorbic Acid for Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE2
Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy
- Status
- COMPLETED
- Phase
- N/A